Correction: Regucalcin promotes dormancy of prostate cancer.
Sharma S, Pei X, Xing F, Wu SY, Wu K, Tyagi A, Zhao D, Deshpande R, Ruiz MG, Singh R, Lyu F, Watabe K.
Sharma S, et al. Among authors: ruiz mg.
Oncogene. 2024 Nov 11. doi: 10.1038/s41388-024-03216-9. Online ahead of print.
Oncogene. 2024.
PMID: 39528817
No abstract available.